David Devos

David Devos is a Scientific Advisor at AbFero Pharmaceuticals. David is also a Professor of Medical Pharmacology, University of Lille, France. Dr. Devos’s main research interests are preclinical and clinical studies of disease-modifying strategies in

neurodegenerative diseases, particularly Parkinson’s disease.